Boston Scientific Corporation · NYSE:BSX
Boston Scientific — Merger or Acquisition (January 2024)
8 slides from Boston Scientific's merger presentation, Jan 8, 2024
Slide 1: Boston Scientific Acquisition of Axonics, Inc.
Boston Scientific Acquisition of Axonics, Inc. January 8, 2024 Exhibit 99.2
Slide 2: Forward-looking statements
2 Certain statements that we may make from time to time, including statements contained in this presentation and information incorporated by reference herein, constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Excha
Slide 3: Summary
Summary Boston Scientific has entered into a definitive agreement to acquire Axonics, Inc., a rapidly growing medical technology company that offers innovative devices to treat urinary and bowel dysfunction, in a transaction that values the company at $3.4B. The Axonics product portfolio, which is h
Slide 4: Company Overview
•Founded in 20121, Axonics, Inc. is a medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction •Headquartered in Irvine, CA with ~800 employees; products available in more than 20 countries •Launched first
Slide 5: Axonics Overview
In a retrospective study, SUI bulking hydrogel demonstrated clinical efficacy up to seven years post treatment5 Axonics Overview Innovative devices to treat urinary and bowel dysfunction Annual Revenue YTD 20236 Gross Margin: ~75% Axonics technologies well-positioned in a large, underpenetrated inco
Slide 6: Boston Scientific + Axonics Highlights
Boston Scientific + Axonics Highlights ➢ Leaders in urology with broad and deep portfolio of industry leading technologies for treating urological conditions ➢ Ability to utilize capabilities and reach to accelerate growth ➢ Proven track record of expanding Urology portfolio for physicians and patie
Slide 7: Appendix
Boston, Scientrfic Appendix
Slide 8: Sources Slide
Sources Slide 4 1 Founded in March 2012 under the name “American Restorative Medicine, Inc.” In August 2013, the Company’s name was changed to Axonics Modulation Technologies, Inc. and operations commenced in late 2013. 2 2023 guidance and reported YTD 2023 actuals: • Jan 8, 2024 Preliminary Net Rev
Boston Scientific — Merger or Acquisition (January 2024) on 6ix